Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Southern Copper Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Southern Copper Corp trades at $201.99 (market cap $169.35B). The key difference: Southern Copper Corp is far larger — about 36× Definium Therapeutics Inc. Common Shares's market cap, and Southern Copper Corp pays a 2.19% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Southern Copper Corp for 61 Days on average.
| DFTX | SCCO | |
|---|---|---|
Market Cap | $4.71B | $169.35B |
Volume | 1,966,636 | 719,187 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $219.70 |
52-Week Low | $10.68 | $120.02 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $3.67B | $170.64B |
Dividend Yield | — | 2.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Southern Copper (SCCO) trades at $198.66, down 2.74% amid broader copper sector weakness. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $1.99 versus $1.94 forecast, continuing a trend of earnings outperformance. Revenue growth accelerated to $13.42B in 2025 with net margins expanding to 35.87%, while technical indicators remain neutral with support at $196. The company maintains robust profitability with 50.07% ROE and recently announced a $1.10 dividend payable August 27, 2026.
SCCO presents a mixed investment case with exceptional profitability metrics offset by premium valuations (P/E 30.1) and analyst skepticism. Near-term catalysts include Q3 earnings due soon and continued execution on $10.2B Mexican growth projects. Primary risks involve copper price volatility and valuation concerns highlighted by Seeking Alpha's premium assessment. Despite 10.34% buy ratings, the consensus price target of $164.33 suggests 17% downside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
